In this task, you're given a paragraph and title from the research paper. Your task is to classify whether the given title is suitable or not for the research paper based on the given paragraph. Return "True" if title is proper according to paragraph else "False".

Q: Paragraph: The Mediterranean diet is rich in fruits and vegetables, monounsaturated fatty acids from olive oil, and is complemented with the traditional use of culinary and medicinal herbs and spices. An important feature of this diet is the negative association with the incidence of metabolic syndrome, which is characterized by increased risk of cardiovascular disease. Conformity to the Mediterranean diet has also been linked to a decreased risk of cardiovascular disease and cancer in US populations. Plants that originated in the Mediterranean basin have been used for centuries in botanical therapies. Many of these plants are believed to prevent and/or cure a wide spectrum of ailments based on their content in bioactive components that exert anti-oxidant, anti-infl ammatory, anticarcinogenic, anti-diabetic, and anti-thrombotic functions. This chapter underlines the health benefi ts that may derive from utilization through dietary assumption or medicinal applications of a selected group of plant products including extracts and specifi c bioactive components found in rosemary, licorice, chamomile, and olive oil. Each section provides a scientifi c analysis of the most recent literature and attempts to highlight the mechanisms of action and molecular targets of bioactive components derived from these plants. 
 Title: Health Benefi ts of Traditional Culinary and Medicinal Mediterranean Plants

A: False
****
Q: Paragraph: Hepatitis C Virus (HCV) infects 2% of the world's population and is the leading cause of liver disease and liver transplantation. It poses a serious and growing worldwide public health problem that will only be partially addressed with the introduction of new antiviral therapies. However, these treatments will not prevent re-infection particularly in high risk populations. The introduction of a HCV vaccine has been predicted, using simulation models in a high risk population, to have a significant effect on reducing the incidence of HCV. A vaccine with 50 to 80% efficacy targeted to high-risk intravenous drug users could dramatically reduce HCV incidence in this population. Virus like particles (VLPs) are composed of viral structural proteins which self-assemble into non-infectious particles that lack genetic material and resemble native viruses. Thus, VLPs represent a safe and highly immunogenic vaccine delivery platform able to induce potent adaptive immune responses. Currently, many VLP-based vaccines have entered clinical trials, while licensed VLP vaccines for hepatitis B virus (HBV) and human papilloma virus (HPV) have been in use for many years. The HCV core, E1 and E2 proteins can self-assemble into immunogenic VLPs while inclusion of HCV antigens into heterogenous (chimeric) VLPs is also a promising approach. These VLPs are produced using different expression systems such as bacterial, yeast, mammalian, plant, or insect cells. Here, this paper will review HCV VLP-based vaccines and their immunogenicity in animal models as well as the different expression systems used in their production. 
 Title: Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

A: True
****
Q: Paragraph: Correspondence: Mingyue Zhu (mingyuezhu2002@163.com) or Mengsen Li (mengsenli@163.com) α-fetoprotein (AFP) is an early serum growth factor in foetal embryonic development and hepatic oncogenesis. A growing number of investigations of AFP as a tumour-specific biomarker have concluded that AFP is an important target for cancer treatment. AFP also plays an immunomodulatory role in the treatment of several autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, myasthenia gravis and thyroiditis. In an effort to support biochemical screening and drug design and discovery, we attempted to express and purify human AFP in a Bac-to-Bac system. Two key factors affecting the expression of recombinant human AFP (R-AFP), namely the infectious baculovirus inoculum volume and the culturing time post-infection, were optimized to maximize the yield. We achieved a high yield of approximately 1.5 mg/l of harvested medium with a 72-96 h incubation period after infection and an inoculum volume ratio of 1:100. We also assessed the role of R-AFP in the proliferation of the human liver cancer cell line Bel 7402, and the results indicated that R-AFP promoted the growth of hepatoma cells. We concluded that this method can produce high yields of R-AFP, which can be used for studies related to AFP. 
 Title: Expression and bioactivity of human α-fetoprotein in a Bac-to-Bac system

A:
True
****